当前位置:首页 - 行情中心 - 益佰制药(600594) - 财务分析 - 利润表

益佰制药

(600594)

4.83

-0.03  (-0.62%)

今开:4.86最高:4.86成交:1.44万手 市盈:0.00 上证指数:2975.82   -0.10%2019-10-17
昨收:4.86 最低:4.80 换手:0.00%振幅:0.00 深证指数:9652.73  0.11%13:13:59

集合

竞价

利润表

按照会计年度查询:
报告期2019-06-302019-03-312018-09-302018-06-30
一、营业总收入1,608,882,256.8824,625,331.832,911,496,482.281,892,703,843.32
营业收入1,608,882,256.8824,625,331.832,911,496,482.281,892,703,843.32
二、营业总成本1,499,637,353.74750,768,138.242,685,563,385.641,699,910,880.16
营业成本392,353,432.86193,018,473.32762,091,761.83504,369,958.59
营业税金及附加20,920,310.15--44,950,916.9828,833,179.01
销售费用834,794,701.92441,385,558.331,439,108,805.69872,936,643.93
管理费用161,605,872.0582,342,710.05293,616,023.52221,836,137.07
财务费用16,979,433.01612,384.2865,257,717.9542,019,963.76
资产减值损失30,462,023.17-20,766.5329,787,335.4429,914,997.8
三、其他经营收益-1,199,528.09365,813.23----
允许价值变动净收益--------
投资净收益-408,184.04-51,875.7-69,156.46-16,317.95
联营、合营企业投资收益--------
汇兑净收益--------
四、营业利润126,649,158.3578,394,468.72248,527,495.01210,023,260.17
营业外收入42,438.93-292,668.1510,507,811.025,941,567.03
营业外支出3,325,392.223,190,505.8714,262,234.0612,357,552.64
非流动资产处置净损失--------
五、利润总额123,366,205.0674,911,294.7244,773,071.97203,607,274.56
所得税30,141,386.7820,831,054.2733,692,895.7130,223,819.16
未确认的投资损失--------
六、净利润(百万元)102.2159.23-725.5196.31
少数股东损益-8,986,644.05-5,150,557.814,766,790.847,397,513.45
归属于母公司股东的净利润102,211,462.3359,230,798.23196,313,385.42165,985,941.95
七、每股收益0.130.080.25--
基本每股收益0.130.080.250.21
稀释每股收益0.130.080.250.21
TOP↑